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Abstract 
Spinal cord injury (SCI) due to acute intervertebral disc extrusions (IVDE) is common in 
dogs and is treated by surgical decompression. Dogs with sensorimotor complete injuries 
have an incomplete recovery. Pulsed electromagnetic fields (PEMF) reduce postoperative 
pain through anti-inflammatory effects and there is growing evidence for neuroprotective 
effects. This randomized, controlled clinical trial evaluated the effect of PEMF on post-
operative pain and neurologic recovery in dogs with surgically treated sensorimotor 
complete SCI due to acute IVDE. 
 
Sixteen dogs with surgically treated complete thoracolumbar SCI were randomized to 
receive PEMF (15 minutes every 2 hours for 2 weeks then twice daily for 4 weeks) or 
placebo starting immediately after diagnosis. The primary outcome was gait score at 2 
weeks. Secondary measures of gait, pain perception and proprioceptive function were 
evaluated at 2 and 6 weeks. Plasma GFAP concentration was measured as a SCI biomarker. 
Post-operative pain was quantified by measuring mechanical sensory thresholds (MST) at 
control and surgical sites.  
 
There was no significant difference in demographics or GFAP concentration between the 2 
groups at trial entry. There was no difference in primary outcome or in secondary 
measures of gait, but proprioceptive placing was significantly better at 6 weeks and GFAP 
concentrations were significantly lower at 2 weeks in the PEMF group. MSTs were 
significantly higher in the PEMF treated group. 
 
We conclude that PEMF reduced incision-associated pain in dogs following surgery for 
IVDE and may reduce extent of spinal cord injury and enhance proprioceptive placing. 
Larger clinical trials are warranted.  
Keywords: spinal cord injury; biomarker; GFAP; hemilaminectomy; pain 
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Introduction 
Certain breeds of dog are predisposed to early degeneration of their intervertebral discs, 
causing calcification of the nucleus pulposus. This in turn may result in acute extrusion of 
the degenerate nuclear material into the overlying vertebral canal, causing contusion and 
compression of the spinal cord1. The majority of dogs with acute, severe thoracolumbar 
intervertebral disc extrusions (TL-IVDE) are managed by surgical decompression, and 
subsequent rehabilitation2,3. After surgery, approximately 60% of dogs suffering the most 
severe grade of injury, sensorimotor complete injury, equivalent to Abbreviated Injury 
Scale (AIS) A, will make a successful, if incomplete recovery while the rest remain 
paralyzed4-6. The acute nature of the injury, along with the location at the thoracolumbar 
junction, well above the level of the lumbosacral intumescence and cauda equina in the 
dog, make this naturally occurring spinal cord injury (SCI) a useful model of human 
traumatic SCI7. The medical and surgical treatment of and recovery from acute TL-IVDE 
have remained essentially static for the last few decades and there has been a renewal in 
efforts to improve outcome, particularly given the translational potential of discovery in 
this naturally occurring model of SCI.  
Recent randomized, controlled clinical trials of neuroprotective strategies have failed 
to show benefit of polyethylene glycol, methylprednisolone sodium succinate or N-
acetylcysteine8,9. A trial of GM6001, a matrix metalloproteinase inhibitor showed a 
beneficial effect on bladder compliance and highlighted a possible response to DMSO in 
the most severely injured dogs that needs to be confirmed in a larger clinical trial10,11. Post-
operative management and subacute therapies have not received much attention, and 
there are limited data on post-operative incisional and neuropathic pain in these dogs. Low 
level laser therapy and acupuncture have been assessed clinically, but most trials have not 
been performed in a blinded or randomized fashion12-15. Targeted pulsed electromagnetic 
fields (PEMF) have been investigated in a wide range of clinical settings in people16.   
Placebo-controlled, double blind, randomized clinical trials of targeted PEMF after breast 
reconstruction surgery reported a significant reduction of patient reported pain, use of 
narcotics and inflammatory cytokines (IL1-)17-19. There is also evidence of control of 
osteoarthritis pain using these devices, although the clinical relevance of the benefit 
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conferred is unclear20. More recent experimental work has investigated the effect of PEMF 
on traumatic brain injury (TBI)21 and SCI22 and other effects of PEMF on neuronal and glial 
health are emerging. Together these data suggest low frequency PEMF might improve 
neurologic outcomes following traumatic injury to the brain and spinal cord. A device has 
been developed to deliver PEMF to dogs by Assisi® based on human devices tested in 
clinical trials. The aim of this randomized, blinded, placebo-controlled trial was to 
investigate the effect of targeted PEMF using this veterinary device on the neurologic 
outcome and post-operative pain in dogs with acute, severe TL-IVDE undergoing 
decompressive surgery.  
  
Material and Methods 
Study Design and Animals 
This study was designed according to the CONSORT guidelines23 and was conducted in 
accordance with guidelines and approval of the North Carolina State University 
Institutional Animal Care and Use Committee (protocol number: 15-177-O). Given the lack 
of data on the magnitude of treatment effect of PEMF in this model, the study was 
designed as a pilot with a view to determining whether a larger scale study should be 
undertaken. A power calculation was performed with an online calculatora  using 
prospectively gathered open field gait scores (OFS) from dogs with complete sensorimotor 
loss due to acute TL-IVDE24. Seven dogs were needed per group to detect a 3-point 
improvement in OFS (representing a clinically relevant functional improvement) 2 weeks 
after injury with a power of 90%. Group size was increased to 8 dogs per group to allow for 
case attrition. This group size also allowed detection of a 3-point difference in OFS 
between groups 6 weeks after injury with a power of 80%. 
Inclusion criteria were: weight ≤ 20 kg; 2 to 12 years of age; acute onset of paraplegia 
with no pain perception in either pelvic limb or the tail; 2 days or less duration of non-
ambulatory status (from the last time owner saw the dog walking) prior to presentation; 
neuroanatomic diagnosis of third thoracic to third lumbar (T3-L3) spinal cord segments 
based on assessment of spinal reflexes; diagnosis of acute TL-IVDE to be treated surgically. 
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Exclusion criteria included systemic comorbidity that might affect functional recovery such 
as diabetes mellitus; signs of progressive myelomalacia (neuroanatomic localization more 
extensive than site of disc extrusion)25; behavior that would prevent appropriate handling 
and data collection. Prior treatment with steroids did not exclude patients due to lack of 
demonstrated effect on outcome8. Owners of dogs that met the inclusion criteria signed 
an informed consent upon presentation, and final entry into the trial occurred 
immediately after the diagnosis was established by cross-sectional imaging. 
Randomization  
Dogs were randomly assigned to either PEMF therapy or placebo in a 1:1 ratio using 
permuted block randomization (block size = 4). The randomization sequence was 
determined by Assisi® and they prepared the active and placebo kits to look identical. Each 
was identified by a serial number and included 4 automatic coils, 1 manual coil and usage 
instructions. They were stored in the NC State Veterinary Hospital pharmacy and used 
consecutively following their number to ensure the randomization was followed. The NC 
State pharmacy had the key to the randomization sequence and checked the coils were 
appropriately active or inactive using a field detector each time a new case was recruited. 
Treatment group identity was masked from the clinicians and technicians working with the 
cases and their owners.  
Case Management 
Diagnosis and treatment of IVDE  
All dogs were managed according to the standard of care provided at NC State Veterinary 
Hospital.  Dogs underwent a physical and neurological examination, as well as routine 
blood work (complete blood cell count, serum biochemistry panel if not already performed 
by the referring veterinarian) and urinalysis at time of admission. Establishing a diagnosis 
and undergoing surgical decompression was considered an emergency, and was pursued 
as soon as possible after admission. The thoracolumbar spine was imaged either with 
computed tomographyb (CT) performed under sedation (using intravenous (IV) 
dexmedetomidinec and hydromorphoned) or MRIe performed under general anesthesia 
(premedication with IV fentanylf, induction with IV propofolg and maintenance with 
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inhaled isofluraneh and oxygen mixture) depending on availability of imaging modality. 
Once the presence of a disc extrusion was confirmed, the patient was transferred for 
surgical preparation. For those dogs that had undergone CT, general anesthesia was 
induced using IV propofol and maintained with an inhaled isoflurane and oxygen mixture.  
All dogs had a fentanyl continuous rate infusion (CRI) during surgery.  The hair on the back 
was shaved, the surgical site prepared and a hemilaminectomy was performed over the 
site of the disc extrusion and extended until all extruded material had been removed. 
Fenestration of the intervertebral discs at T11/12 to L2/3 was performed to reduce the risk 
of a recurrence2. The surgical incision was closed routinely and the dog recovered from 
anesthesia. Post-operative pain was managed in all dogs using the same protocol that 
included a combination of opiates, non-steroidal anti-inflammatory drugs and gabapentin 
(Table 1). Management of the surgical incision and rehabilitation was also standard for all 
dogs and included cryotherapy by application of an ice-packk to the incision for 10 minutes 
every 12 hours for the first 48 hours after surgery. After this time, the incision was hot-
packed for 10 minutes every 12 hours using a hot-packl heated in the microwave for 2 
minutes on high setting for the remaining 5 days of hospitalization. All dogs were housed 
in individual cages that were lined with 4-inch foam pads to ensure no interference from 
the stainless-steel cage walls. They were confined to their cage for the 7 days of 
hospitalization. They had passive range of motion (PROM) exercises performed on both 
pelvic limbs, 15 repetitions every 12 hours and they were sling walked outside every 8 
hours for urination and defecation. If unable to urinate, their bladder was manually 
expressed, aided by treatment with oral diazepamm (0.5mg/kg q 8 hours) and 
phenoxybenzaminen (0.5mg/kg q12 h). If the bladder was still difficult to empty on this 
drug combination, prazosino (0.02mg/kg q12h) was substituted for phenoxybenzamine. 
This was continued until voluntary urination was documented.  
After 1 week, dogs were discharged to their owners with a set of written instructions 
on their care. All owners were instructed in how to perform PROM, sling walking and 
bladder expression. They were asked to keep their dogs confined to a well-padded small 
area, to perform PROM twice daily until the 6-week end point and to sling walk them on a 
non-slip surface for elimination 2 – 3 times a day. After the 2-week primary end point, they 
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were asked to gradually increase the time spent outside sling walking by 2 minutes every 
other day, and to allow them to bear more weight on their pelvic limbs as dictated by their 
neurologic function. They returned for re-evaluations 2, 4 and 6 weeks after their surgery. 
Life-threatening adverse events that occurred at any point in the 6-week course of the trial 
were reported to the study safety monitor who was charged with investigating possible 
associations between life-threatening adverse events and treatment group. 
PEMF treatment 
Treatment with PEMFp was initiated as soon as diagnosis of IVDE was confirmed with the 
first treatment administered while the dog was being prepared for surgery. The center of 
the loop was placed over the disc extrusion site and the loop was turned on. Treatment 
was delivered for 15 minutes after which the loop was removed and surgery was 
performed. On completion of surgery, a soft jacket was placed on the dog and the loop 
fixed into the correct place with Velcro tags and left in place (Figure 1). The loops were 
programmed to go into “stand by” mode for 2 hours and then to switch to 15 minutes of 
treatment with 2-hour interspaces until turned off. This treatment cycle was based on 
human clinical protocols aimed at the acute injury and repair phase26 During the 15-
minute treatments, two indicator lights blinked every second, and between treatments, 
one indicator light blinked approximately every 6 seconds, indicating the loop was in 
stand-by mode. Both active and inactive (placebo) loops, appeared identical. The 
automated loops were replaced every 4 days until the 2-week primary study endpoint to 
ensure that there was no battery failure. Owners were given the replacement loop they 
needed with instructions of when to change it out. At the 2-week time point, owners were 
given a manual loop and instructed to place and turn on the loop twice a day for the 15-
minutes programmed treatment, during which time they were to perform the PROM 
exercises.  The loop was then turned off automatically and removed. This manual 
treatment occurred for the next 4 weeks until the 6-week secondary end point, based on 
results of extended treatment to relieve pain in people27.  Each owner was given a logbook 
and a questionnaire to record information on a daily basis.  
  
D
ow
nl
oa
de
d 
by
 N
CS
U
 N
or
th
 C
ar
ol
in
a 
St
at
e 
U
ni
ve
rs
ity
 fr
om
 o
nl
in
e.
lie
be
rtp
ub
.c
om
 a
t 0
1/
10
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 9 of 41 
 
 
 
9 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Th
e 
ef
fe
ct
 o
f e
le
ct
ro
m
ag
ne
tic
 fi
el
ds
 o
n 
po
st
op
er
at
iv
e 
pa
in
 a
nd
 lo
co
m
ot
or
 re
co
ve
ry
 in
 d
og
s w
ith
 a
cu
te
, s
ev
er
e 
th
or
ac
ol
um
ba
r i
nt
er
ve
rt
eb
ra
l d
isc
 e
xt
ru
sio
n:
 a
 ra
nd
om
ize
d 
pl
ac
eb
o-
co
nt
ro
lle
d,
 p
ro
sp
ec
tiv
e 
cli
ni
ca
l 
tr
ia
l. 
(D
OI
: 1
0.
10
89
/n
eu
.2
01
7.
54
85
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
Data collection 
Data collected from each dog included signalment (body weight, body condition score, 
breed, sex, and age), history including owner reported details of duration of onset (defined 
as time from onset of pain or paresis to paralysis and categorized as < 1 day, 1 - 3 days, 4 - 
7 days, 8 – 14 days) and duration of paralysis (defined as time of onset of paralysis to 
presentation and categorized as < 12 h, 12 – 24 h, 24-48 h)), preoperative neurologic 
status, location of disc extrusion, site of hemilaminectomy, details of drugs used for pain 
management, and adverse events (defined as any adverse medical occurrence that 
developed during the course of the study).  
Physical and neurologic examinations were performed daily on all dogs by the same 
clinician (NZ, blinded to treatment group) during the 1-week hospitalization and at the 2, 4 
and 6 week revaluations. Evaluation included categorization of gait as ambulatory 
paraparetic (> 10 consecutive weight-bearing steps), nonambulatory paraparetic or 
paraplegic. Proprioceptive placing of each pelvic limb (the ability to replace the foot after 
the investigator knuckles it to place the dorsal surface on the ground) as well as hopping 
reaction, pain perception in the tail and each pelvic limb were scored as absent (0), 
delayed/decreased (1), or normal (2). The first day of recovery of pain perception in either 
limb or the tail was logged, specific to the day if in the first week, or the time period 
between rechecks if after discharge at the end of the first week. The patellar and 
withdrawal reflexes were scored as absent (0), delayed/decreased (1), normal (2), 
increased (3), or clonic (4). The caudal level of the cutaneous trunci reflex was recorded 
according to the vertebral level28.  The number of days to independent walking (ability to 
take 10 consecutive weight-bearing steps) and voluntary urination was recorded. Pain 
assessment was performed daily while hospitalized, and on the recheck days using three 
different scales: Glasgow Pain Scale29, Surgical Site Manipulation Score (Supplementary 
data 1), and by measurement of mechanical sensory thresholds (MSTs) using an algometer 
(Figure 2). Pressure algometry was performed by the same observer (NZ) in triplicate at 
each assessment. Measurements were first made at the level of the first to third thoracic 
vertebrae (control site) by applying the algometer to the paraspinal muscles and increasing 
manual pressure until the dog showed a behavioral response such as moving away, looking 
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around or vocalizing. They were then repeated at the level of the IVDE (the 
hemilaminectomy site) (Figure 2). The mean MST for the control and surgical sites were 
calculated for each time point as well as the difference in MST between the control and 
surgical sites.  
Dogs were videotaped walking on a non-slip surface (a carpet runner) and on a 
treadmill on day 1 (day after surgery), then again on days 3, 7, 14, 28 and 42 post-
operatively using previously described protocols30,31. Dogs were only evaluated on the 
treadmill if able to walk independently on that surface. A video camera was placed to 
obtain images from the side and behind when the dog was walking on the carpet, and in a 
specific position to capture all four limbs when using the treadmill. On the treadmill, they 
were walked without support at a speed adjusted to achieve the pace that appeared most 
comfortable to them and at least 3 minutes of continuous walking was recorded. Videos 
were identified by randomized numbers and scored by a blinded observer (JF) to generate 
a modified OFS (Supplementary data 1) for walking on the non-slip surface8,32, as well as a 
regularity index (RI) to quantify thoracic limb, pelvic limb coordination while walking on 
the treadmill31,33. 
Other measurements obtained included bladder volume before and after urination 
using ultrasound34.  This was recorded daily in the first week, then again on days 14, 28 
and 42, or until normal voiding (>80% voiding) was achieved. In addition, blood samples 
were drawn into EDTA on the day of presentation, as well as days 1, 2 and 14 and banked 
in a -80oC freezer for measurement of plasma concentrations of glial fibrillary acidic 
protein (GFAP) to be used as a biomarker of injury severity35. At the end of the study, this 
structural biomarker was measured using an ELISA kitq as per the manufacturer’s 
guidelines. Measurements were made in duplicate and mean values were calculated.  
Statistical Analysis 
Summary data were prepared on the demographics, clinical history, site of IVDE and 
hemilaminectomy as well as plasma GFAP concentrations at time of presentation and were 
compared between groups. Wilcoxon 2-sample tests were used to compare age, body 
weight, body condition score, and GFAP. Fisher’s Exact Tests were used to compare breed, 
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duration of signs, and time of paralysis prior to surgery.  
The primary outcome measure was gait quantification by OFS at 2 weeks after injury. 
The secondary outcome measures included GFAP concentration at day 14, RI (as a 
measure of quadrupedal coordination) at day 14 and 42, as well as time to independent 
walking in days, proprioceptive placing score, hopping score, pain perception presence (Y 
or N), voluntary urination (Y or N), independent walking (Y or N) on days 14 and 42, OFS on 
day 42 and the measures of post-operative pain (Glasgow pain score, surgical 
manipulation score, and MST) on days 3, 7, 14 and 42. OFS between groups was compared 
using ANOVA as well as ANCOVA using GFAP at time zero as the covariate. RI was 
compared between groups using logistic regression (following conversion of RI to a binary 
product due to the large number of dogs scoring 0 at 2 weeks). The analysis was 
performed with and without GFAP concentrations at time zero as an effect in the model. 
For the 3 measures of post-operative pain that were scored on multiple days, repeated 
measures ordinal logistic regression model (Glasgow pain score and surgical manipulation 
score) and repeated measures ANOVA (MST) were fit, allowing for the effects of group and 
day. The remaining secondary outcome measures were evaluated by one-way ANOVA 
(OFS and RI at day 42), logistic regression (walking, pain, voluntary urination, yes or no on 
days 1, 14 and 42), ordinal logistic regression (proprioception and hopping scores on days 
14 and 42) and nonparametric Wilcoxon test (GFAP concentration day 14).  
 
Results  
Seventeen dogs fit the inclusion criteria for clinical trial enrollment at time of presentation. 
One dog was not included due to MRI changes consistent with progressive myelomalacia. 
Sixteen dogs were enrolled and successfully completed their 1-week in hospital 
postoperative treatment and returned for the 14 and 28 day rechecks.  Fifteen of 16 
returned for the 42nd day recheck, 1 dog in the PEMF group was lost to follow up. This dog 
was paraplegic with no pain perception in either pelvic limb or tail at the day 28 recheck 
and the data was handled conservatively using the last observation carried forward (LOCF) 
convention (Figure 3).  
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Group characteristics  
The majority of dogs in the study were Dachshunds (9/16: 56%) dogs, 4 in the active 
treatment group and 5 in the placebo group. There were also 5 mixed breed dogs, 1 Beagle 
and 1 French bulldog. Their median age was 4 years, ranging from 2 to 11 years. Breed, 
age, sex, body weight, body condition score of the participating dogs did not differ 
significantly among treatment groups (Table 2).  All dogs had sensorimotor complete 
injuries that localized to the T3 – L3 spinal cord segments (as required for inclusion), and 
there was no significant difference between groups in plasma concentrations of GFAP at 
the time of presentation (Table 2).  The duration of clinical signs prior to presentation and 
duration of inability to walk did not differ significantly between treatment groups (Table 
2). L2-3 was the most common site of IVDE (n = 4), followed by L1-2 (n = 3); T11-12, T13-L1 
and L3-4 (n = 2 each), and T12-L1, T12-13 and L4-5 (n = 1 each).  
In-patient care  
All dogs were managed with the standard post-operative medication protocol with no 
dogs requiring additional opiates for pain control.  Six dogs in the PEMF group received 
carprofen, and it was discontinued in 1 of these dogs on day 2 due to development of 
diarrhea. Of the remaining 2 dogs in PEMF group, 1 received a tapering course of 
prednisone and 1 did not receive an anti-inflammatory due to intermittent regurgitation 
from the time of admission. In the placebo group, 5 dogs received carprofen, 1 received a 
tapering course of prednisone and 2 did not receive any anti-inflammatory medications 
due to vomiting (n=1) and diarrhea (n=1). All 8 dogs in the PEMF group were administered 
diazepam for the 7 days of hospitalization, in combination with phenoxybenzamine for 6/8 
to facilitate bladder expression. Diazepam was administered to 6/8 dogs in the placebo 
group, in combination with phenoxybenzamine (n=4) and prazosin (n=2). Two dogs had 
easily expressible bladders without medications.  Two dogs in each group received 
trazadoner (12.5 - 100mg/dog PO q8h or as needed) for anxiety while hospitalized. Eight 
dogs, 4 in each group, had adverse events in the first week. Five dogs developed 
gastrointestinal signs (diarrhea (n=3, 2 PEMF and 1 placebo group), vomiting (n=1, placebo 
group) and regurgitation (n=1, PEMF group). One dog (PEMF group) developed hematuria 
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with a negative urine culture, 1 dog (placebo group) developed a urinary tract infection, 1 
dog (placebo group) developed a superficial pyoderma, and 1 dog (placebo group) 
dislodged and ate its treatment coil on day 3 (a new coil was placed within 3 hours). The 
dog was monitored, but the pieces of coil remained in the stomach (detected on 
abdominal radiographs 10 days after consumption) and so on day 17 the dog was 
anesthetized and the coil pieces were retrieved via endoscopy. The dog never showed any 
clinical signs related to the coil ingestion. Two more dogs damaged their coils by chewing 
them in the second week once discharged to their owners, 1 dog chewed 1 coil, and 
another dog chewed 2 coils. Both dogs were in the placebo group and neither actually 
consumed their coils. Two of the 3 were replaced promptly but one dog (Dog 11) missed 
treatments for 3 days (days 15 – 17). All adverse events responded to treatment 
(Supplementary data 1). 
Clinical recovery 
At time of presentation, all dogs were paraplegic with no pain perception, however on the 
day after surgery, 4/8 dogs in the PEMF group regained pain perception (while remaining 
paraplegic) compared with 0/8 dogs in the placebo group, by day 14, 6/8 dogs in the PEMF 
and 5/8 in the placebo group had recovered pain perception and by day 42, 6 dogs in each 
group were able to feel their pelvic feet and tail (Table 3). Independent walking was first 
observed in 1/8 dogs in the PEMF group on day 7, 2/8 dogs in the PEMF group and 3/8 
dogs in the placebo group were walking by 14 days and this increased to 4/8 in each group 
by day 42. Five/8 dogs were urinating voluntarily by day 14 in the PEMF group compared 
with 3/8 in the control group and this did not change by day 42 (Table 3).   
Biomarker changes 
Median plasma GFAP concentrations increased from day 0 to day 1 in the PEMF group and 
then decreased by day 14, while the median plasma GFAP concentration increased 
through day 2 in the placebo group before decreasing again by day 14 (Figure 4), with 
values in the placebo group tending to be higher than the PEMF group throughout. This 
was most obvious by day 14 when GFAP could not be detected in the plasma of any of the 
dogs in the PEMF group.  
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Primary outcome 
On day 14, the median OFS in the PEMF group was 2.5 (IQR: 1.25-7.25) and in the placebo 
group was 2.5 (IQR: 1-6). There was no significant difference between the 2 groups when 
comparing OFS alone and using GFAP concentration at time 0 as a covariate (P = 0.73 and 
0.84 respectively).  
Secondary outcome measures 
The median RI on day 14 was 0 in both groups and because RI was 0 in 6 dogs in each 
group, RI scores were assigned a binary category with scores <10 assigned to 0 and >10 
assigned to 1.  Logistic regression was performed with treatment group and GFAP 
concentration as effects in the model. The overall model was not significant (p = 0.57) and 
neither group nor GFAP concentration at time 0 were significant (p = 0.48 and p = 0.67, 
respectively). Group did not become statistically significant upon removal of GFAP from 
the model (p = 0.53). Time to independent walking was analyzed with a proportional 
hazards regression with missing observations (i.e. dogs that had not recovered 
independent walking) censored at day 42. There was no significant difference between 
groups (p=0.96). The remaining secondary outcome measures related to functional 
recovery are listed in Table 3. There was no significant difference between groups in the 
recovery of pain perception, hopping ability, and motor or bladder function by day 42. 
However, when considering proprioceptive placing, by day 42, none of the dogs in the 
placebo group had any proprioceptive placing (score of 0) while 4 dogs in the PEMF group 
had positive scores (table 4). When compared using logistic regression, the difference was 
significant (p=0.005). Plasma GFAP concentrations were significantly higher in the placebo 
group 14 days after injury (p = 0.019). 
Post-operative pain 
Post-operative pain scores were compared between groups as they evolved over days 3, 7, 
14 and 42.  For the Glasgow pain scale, the vast majority of observations were 0, with only 
8 of a total of 64 observations scoring more than 0 (ranging from 1 – 5 of a possible total of 
24) in 6 of the 16 dogs. Fitting a repeated measures ordinal logistic regression model 
allowing for effect of day and group, there was no significant difference between the two 
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groups (p = 0.44) or between days (p = 0.31).  Likewise, the vast majority of the surgical 
site manipulation scores were zero with only 5 dogs scoring 1 in the first week and 1 dog 
scoring 2 on day 14. Fitting a repeated measures ordinal logistic regression model allowing 
for effect of day and group, there was no significant difference between groups (p = 0.55). 
However, there was a significant decrease in surgical site manipulation scores over time (p 
= 0.022). Mechanical thresholds at the control and surgical site are presented in Table 5. 
Fitting a repeated-measures ANOVA to these data, allowing for the effects of group and 
day (and a subject effect to take into account the within-subject correlation), neither 
group nor day were statistically significant at the control site (p=0.36 and p=0.08 
respectively). When the MSTs at the surgical site were evaluated, there was a significant 
difference between groups (p=0.03), but not between days (0.06). The data was also 
analyzed by subtracting the MST at the surgical site from the control site in an attempt to 
control for individual variation in responsiveness, and again, there was a significant 
difference between groups (p=0.02) but not days (0.32).  
Discussion 
This randomized, placebo-controlled, blinded clinical trial recruited dogs with 
sensorimotor complete TL-SCI, causing paraplegia with loss of pain perception below the 
level of injury, and evaluated the effect of targeted PEMF on neurologic recovery and post-
operative pain. There was no significant difference in primary outcome (gait score) 
between the groups at 2 weeks, or at the secondary time point, 6 weeks. Evaluation of 
other secondary outcomes revealed a significant difference in recovery of proprioceptive 
placing at 6 weeks, with half of the PEMF treated dogs recovering some proprioceptive 
placing compared with none of the placebo group. Evaluation of GFAP as a biomarker of 
injury suggested that, while clinically indistinguishable at entry into the trial, the placebo-
treated group included dogs with more severe injury. Using pressure algometry to 
measure mechanical sensory thresholds over a 6-week period, PEMF treated dogs had 
significantly higher thresholds than dogs treated with placebo suggesting a significant 
effect on post-operative pain.  
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The mechanism of action of PEMF is likely to be complex. There is in vitro and 
experimental evidence that PEMF modulates the calcium-calmodulin (CaM) nitric oxide 
(NO) cascade16. The small electrical field produced within the targeted tissues increases 
calcium binding by calmodulin, which binds to constitutive nitric oxide synthase (cNOS), 
producing NO with an immediate vasodilatory effect. Nitric oxide catalyzes guanylyl 
synthase, producing cyclic guanosine monophosphate (cGMP).36 Activation of the 
CaM/NO/cGMP pathway downregulates IL1, limiting inflammation and reducing inducible 
NOS (iNOS) activity37 as well as increasing production of FGF2 and VEGF. Indeed, several 
studies have demonstrated PEMF reduce iNOS and proinflammatory cytokines38,39 and 
enhance angiogenesis through increased FGF240. Experimentally, the effect on wound 
repair has been dramatic with a 60% improvement in cutaneous wound repair in rats by 3 
weeks41, and clinically this has translated to reduced IL1 levels, patient scored post-
operative pain and narcotic use after breast reconstruction surgery 18,19,26 although not all 
trials showed the same beneficial effect42. As such, a reduction in post-operative pain and 
improved healing of the surgical incision might be anticipated. Evidence that PEMF might 
be neuroprotective after CNS injury is growing. Early work in a rabbit model of cerebral 
ischemia demonstrated a reduction in ischemic neuronal damage with PEMF43.This 
observation is supported by more recent work in which PEMF delivered after traumatic 
brain injury in rats (via contusive and penetrating injuries) reduced CSF IL1 concentrations 
ten fold21 and in a study of ischemic stroke in mice, PEMF reduced inflammatory mediators 
and increased activation of the BDNF/TrkB/Akt signaling pathway with a beneficial effect 
on outcome44. Application of PEMF to the normal rat brain increases cerebral 
microvascular perfusion and oxygenation45. Thus, it may be possible to limit the 
consequences of spinal cord injury through anti-inflammatory effects and improved 
perfusion. This, together with effects on neurite outgrowth46 led us to hypothesize that 
PEMF may have a beneficial effect on neurological outcome of dogs with acute spinal cord 
injury.  
This clinical trial was designed to examine the effect of PEMF on recovery of pelvic limb 
function, in dogs with acute, severe spinal cord injury due to acute TL-IVDE. The most 
severe grade of injury was chosen because recovery from this grade of injury is 
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incomplete24,47. An early time point in the course of their recovery (2 weeks) was chosen 
as the primary study end point because neurologic recovery at that time, while still 
underway, is relatively uniform and a low number of animals would be needed to detect 
an effect. This strategy would allow rapid decisions on whether a larger, longer-term study 
should be undertaken. The primary outcome for this trial was a robust measure of walking 
ability, and the study was powered to detect a 3-point change because a change of this 
order lifts the dog from one broad category of function to the next. We were unable to 
detect an effect on this outcome at 2 or 6 weeks. We evaluated several different aspects 
of neurologic recovery as a secondary analysis, including categorical outcomes such as 
recovery of independent ambulation, pain perception and bladder function. Overall, 50% 
of dogs in each group recovered independent ambulation, comparable to historical reports 
of this disease4,6. Other more specific evaluations included ordinal scales of proprioceptive 
placing and hopping, as well as continuous measures of quadrupedal coordination (RI). Of 
these, there was a highly significant difference in proprioceptive placing, with 4 of the 
PEMF treated group and none of the control group showing partial or complete recovery 
of this function by 42 days. Proprioceptive placing is the first function lost with spinal cord 
compression and the last to reappear48. This observation, while it may reflect slightly 
different initial injury severity, suggests there may be a small positive effect on recovery of 
neurologic function and a larger clinical trial may be indicated. While the results of 
secondary outcomes should be considered exploratory, this finding shows that the use of 
multiple different assessments allows examination of different functional effects and may 
uncover an important treatment effect.  
A unique facet of this trial was the use of plasma GFAP concentration as a biomarker of 
spinal cord injury severity. The dichotomization of recovery of dogs with sensorimotor 
complete signs into successful recovery versus permanent paralysis underscores the 
variability of severity of spinal cord injury in these cases that cannot be detected clinically 
at time of presentation. Plasma concentrations of S100, phosphorylated neurofilament 
heavy chain (pNFH) and GFAP have been in investigated in dogs with SCI35,49  and of these, 
plasma GFAP concentration was the most discriminating of injury severity among 
sensorimotor complete dogs35. The lack of availability of a bedside test prevented 
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measurement of plasma GFAP concentration at time of trial entry for stratification prior to 
randomization but GFAP concentrations were incorporated as a covariate, lending strength 
to the analysis. While not significantly different at entry into the trial, one dog in the 
placebo group was an outlier with a plasma GFAP concentration of 13ng/mL and likely had 
a much more significant injury. The divergence between the groups increased in the first 
48 hours after injury and at 14 days, GFAP concentrations were significantly higher in the 
placebo group. Indeed, GFAP was undetectable in the PEMF group while 5/8 of the 
placebo group had measureable levels. This divergence over 48 hours could reflect a more 
severe initial injury or a therapeutic effect.  
The standard surgical treatment of TL IVDE is to perform a hemilaminectomy to 
decompress the spinal cord and fenestration of at risk intervertebral discs as a prophylactic 
measure2.  The resulting incision spans approximately 8 vertebrae and involves extensive 
dissection of muscle. The post-operative pain management protocol used in this study was 
standard at our institution, and when dogs were evaluated using both the Glasgow Pain 
Scale and the SSMS their pain appeared to be well controlled. However, pressure 
algometry provided a more noxious stimulus and was more discriminating, clearly 
demonstrating a difference between the 2 treatment groups that was magnified over the 
course of 6 weeks with PEMF treated dogs having progressively higher thresholds 
compared with relatively static thresholds in the placebo group.  From these data we 
hypothesize that PEMF improved healing of the surgical sites in the long term, with a 
resulting decrease in incisional pain. This finding is not unexpected given the results of 
human clinical trials that evaluated the use of PEMF after breast reconstructive 
surgery18,26,50. However, the studies should be compared with caution, because the human 
clinical trials focused on pain levels in the immediate postoperative period (48 hours), 
while this trial followed patients out to 6 weeks and showed a magnifying effect in the 
later stages of recovery. Indeed, the use of our standard analgesic protocol for the first 
week post-operatively may have hidden an early effect of PEMF on pain.  While we could 
speculate on whether we are measuring incisional pain associated with wound healing or 
neuropathic pain associated with a severe spinal cord injury, it is difficult to separate these 
phenomena, and given the location of our testing, we have characterized the MSTs as a 
D
ow
nl
oa
de
d 
by
 N
CS
U
 N
or
th
 C
ar
ol
in
a 
St
at
e 
U
ni
ve
rs
ity
 fr
om
 o
nl
in
e.
lie
be
rtp
ub
.c
om
 a
t 0
1/
10
/1
8.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Page 19 of 41 
 
 
 
19 
Jo
ur
na
l o
f N
eu
ro
tr
au
m
a 
Th
e 
ef
fe
ct
 o
f e
le
ct
ro
m
ag
ne
tic
 fi
el
ds
 o
n 
po
st
op
er
at
iv
e 
pa
in
 a
nd
 lo
co
m
ot
or
 re
co
ve
ry
 in
 d
og
s w
ith
 a
cu
te
, s
ev
er
e 
th
or
ac
ol
um
ba
r i
nt
er
ve
rt
eb
ra
l d
isc
 e
xt
ru
sio
n:
 a
 ra
nd
om
ize
d 
pl
ac
eb
o-
co
nt
ro
lle
d,
 p
ro
sp
ec
tiv
e 
cli
ni
ca
l 
tr
ia
l. 
(D
OI
: 1
0.
10
89
/n
eu
.2
01
7.
54
85
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
measure of incisional pain. However, we are investigating the possibility that there is an 
effect on neuropathic pain in ongoing studies. 
The only complication of this clinical trial was patient interference with the device 
delivering the PEMF. Three dogs, all in the placebo group, damaged their coils by biting 
them, and one dog consumed his coil, necessitating removal via gastroscopy. Dogs wore 
small jackets with the coils held in place by Velcro, and could not reach them directly, but 
one of the dogs managed to rub off the jacket and coil on day 3 of the trial during the 
automated 2 hourly treatment cycle. The other 2 dogs damaged the coils outside the 
treatment time. Clearly, dog owners and hospital staff need to be vigilant to prevent this 
from happening. The significance of interference occurring only in the placebo group is 
unclear. The major limitation of the trial was the relatively low number of animals used. 
The study was specifically designed to limit the number of animals and target an early time 
point to allow rapid decisions to be made on the therapeutic potential. While powered to 
detect changes in motor function, the range of pressure algometry observations between 
animals was extremely narrow, allowing detection of a robust treatment effect.  
Conclusions  
We conclude that targeted PEMF reduce incisional pain over a 6-week period following 
surgical treatment of TL-IVDH. The beneficial effect on proprioceptive placing and GFAP 
levels in the PEMF treated group should be interpreted with caution due to the small 
number of animals used, but suggest a larger phase 3 clinical trial is indicated.  
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Footnotes 
a http://www.statisticalsolutions.net/pssTtest_calc.php 
b CT, Siemens Perspective 64 slice, Cary, NC 
c Dexmedetomidine, Orion, Espoo, Finland 
d Hydromorphone, West Ward pharmaceutics, Eatontown, NJ 
e MRI: 1.5T Siemens Symphony, Cary, NC 
fFentanyl citrate injection, West Ward pharmaceutics, Eatontown, NJ and Fentanyl 
transdermal, Mylan, Morgantown, WV 
g Propofol, Sagent, Schaumburg, IL 
h Isoflurane, Piramal Healthcare, Andhra Pradesh, India 
i Rimadyl®, Zoetis, Lincoln, NE      
j Gabapentin, Method, Fort Worth, TX 
k FlexiKold®, PolyGel, Whippany, NJ 
l Elasto-GelTM, Southwest Technologies, North Kansas City, MO 
m Diazepam, Mylan, Rockford, IL 
n Phenoxybenzamine, compounded by NCSU VH Pharmacy, Raleigh, NC 
o Prazosin, Mylan, Morgantown, WV 
 p Assisi Loop, Assisi Animal Health, Northvale, NJ. Th is FDA-cleared device delivers 
a  signal with the following characteristics: 27.12 MHz carrier, burst at 2 msec, at 2 Hz and 
at 0.05 Gauss. 
q ELISA kit, GFAP, BioVendor, Asheville, NC 
r Trazodone, TEVA, North Wales, PA   
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Tables  
Table 1. Post-operative pain management protocol. * If the dog had received 
corticosteroids, a tapering dose of prednisone was substituted for the nonsteroidal anti-
inflammatory drug and omeprazole (1mg/kg q24 hours) was administered.  
 
  
 Hydromorphone Fentanyl Carprofen*j Gabapentink
Dose & 
route 
0.05 – 0.1mg/kg 
IV 
3 – 5ug/kg Cutaneous 2.2mg.kg 
PO 
8-10mg/kg PO
Frequency Q8h Continuous Q12h Q8h 
Time after 
surgery 
First 24 hours 
then PRN 
Days 1 - 5 Days 1 - 7 Days 1 - 7 
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Table 2: Historical and clinical findings in dogs at time of clinical trial entry . MC: Male 
castrated; FS: Female spayed; F: Female; IQR: interquartile range; BCS: body condition 
score; GFAP: glial fibrillary acidic protein. 
Parameter PEMF Group  
N=8 
Placebo Group  
N=8 
P value 
Breed: Dachshund; Other 
 
4 Dachshunds 
4 Other 
5 Dachshunds 
3 Other 
1 
Age (years): median (IQR) 5.5 (3.25-7.75)  4 (3 – 4.75) 0.48 
Sex 3MC, 3FS, 2F 2MC, 1M, 4FS, 1F NA 
Duration of clinical 
signs  
 
<1 day 1 dog 4 dogs 0.15 
1 – 3 days 4 dogs 1 dog 
4 – 7 days  3 dogs 1 dog 
1 – 2 
weeks 
0 dogs 2 dogs
Duration of non-
ambulatory status  
 
<12h 1 dog 4 dogs 0.46 
12-24h 4 dogs 2 dogs
25-48h 3 dogs 2 dogs 
Imaging modality MRI: 4; CT: 4 MRI: 3; CT: 5 NA 
Body weight: median (IQR) 9.45 (6.55-14.75) 7.85 (4.16-10.23) 0.19 
BCS: median (IQR) 5.5 (5-6.75) 5.0 (5-6) 0.62 
GFAP (ng/ml) Time 0: median (IQR) 0 (0 – 0.26) 0.06 (0 – 0.4) 0.47 
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Table 3: Secondary outcome measures. OFS: open field score; RI: regularity index; Y: yes; 
N: no; IQR: interquartile range; GFAP: glial fibrillary acidic protein. 
 
Variable PEMF Group Placebo Group P value 
OFS Day 42: median (IQR) 5.5 (2.25-8.5) 5.5 (3-7) 0.7 
RI Day 42: median (IQR) 14.55 (0-66.9) 0 (0-17.2) 0.47 
Walking Y/N Day 14: number (%) 2/8 (25%) 3/8 (37.5%) 0.59
Walking Y/N Day 42: number (%) 4/8 (50%) 4/8 (50%) 1 
Pain perception Y/N Day 14: number 
(%) 
6/8 (75%) 5/8 (62.5%) 0.59 
Pain perception Y/N Day 42: number 
(%) 
6/8 (75%) 6/8 (75%) 0.61
Voluntary urination Y/N Day 14: 
number (%) 
5/8 (62.5%) 3/8 (37.5%) 0.32 
Voluntary urination Y/N Day 42: 
number (%) 
5/8 (62.5%) 3/8 (37.5%) 0.2 
Hopping score Day 14: median (IQR) 0 (0-1.5) 0 (0-0) 0.08 
Hopping score Day 42: median (IQR) 1.5 (0-3.25)  0.15 
GFAP (ng/ml) Day 14: median (IQR) 0 (0-0) 0.08 (0-0.27) 0.02 
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Table 4: The number of dogs with specific proprioceptive placing scores on day 42. The 
difference between groups was significant (P=0.005). 
 
 Proprioceptive Placing Score at Day 42 
Group 0  1 2 3 4 
PEMF 3 dogs 0 dogs 2 dogs 1 dogs 1 dogs 
Placebo 8 dogs 0 dogs 0 dogs 0 dogs 0 dogs 
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Table 5: Results of assessment of post-operative pain using pressure algometry. PEMF: 
pulsed electromagnetic field. Values are expressed as median and interquartile range in 
pounds applied.  
 
 Day 3 Day 7 Day 14 Day 42 P 
value 
Control 
site: PEMF 
9.95 (8.87-11) 10 (6.85-11) 11 (8.38-11) 10.6 (9-11) 0.26
Control 
site: 
placebo 
10.15 (6.78-11) 8.2 (6.3-
10.75) 
9.8 (7.7-11) 10.5 (9.48-
11) 
Surgical 
site: PEMF 
6.3 (5.48-9.75) 7.1 (4.78-
9.58) 
7.8 (7.53-
10.75) 
9 (7.3-11) 0.03 
Surgical 
site:  
placebo 
5.3 (3.78-9.65) 5.3 (3.03-
7.45) 
6.8 (4.5-9.23) 6.6 (5.3-8.9) 
Control-
surgical 
site: PEMF 
2.25  
(0.78-4.05) 
2.45  
(0.63-2.93) 
0.85 (0-3.2) 1.3 (0-2.3) 0.026 
Control-
surgical 
site: 
placebo 
3 (1.35-5.28) 2.5 (1.7-3.63) 2 (1.78-3.2) 2.4 (1.48-
4.68) 
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Figure legends 
 
Figure 1: A treatment loop in place in 2 dogs, Velcro straps hold the loop centered over the 
epicenter of the spinal cord injury. 
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Figure 2: Mechanical sensory thresholds were measured using an algometer (a). Pressure 
algometry was performed at a control site between the scapulae (b) and at the level of the 
hemilaminectomy (c) by applying pressure to the paraspinal musculature. Measurements 
were performed in triplicate and the mean score calculated.  
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Figure 3: Consort diagram of the trial. 
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Figure 4: Box and whiskers plots of plasma GFAP concentrations days 0 (trial entry), 1, 2 
and 14. 
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f e
le
ct
ro
m
ag
ne
tic
 fi
el
ds
 o
n 
po
st
op
er
at
iv
e 
pa
in
 a
nd
 lo
co
m
ot
or
 re
co
ve
ry
 in
 d
og
s w
ith
 a
cu
te
, s
ev
er
e 
th
or
ac
ol
um
ba
r i
nt
er
ve
rt
eb
ra
l d
isc
 e
xt
ru
sio
n:
 a
 ra
nd
om
ize
d 
pl
ac
eb
o-
co
nt
ro
lle
d,
 p
ro
sp
ec
tiv
e 
cli
ni
ca
l 
tr
ia
l. 
(D
OI
: 1
0.
10
89
/n
eu
.2
01
7.
54
85
) 
Th
is 
pa
pe
r h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 co
py
ed
iti
ng
 a
nd
 p
ro
of
 co
rr
ec
tio
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f. 
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